Ligand stabilization of CXCR4/delta-opioid receptor heterodimers reveals a mechanism for immune response regulation.
about
Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonistsOpioids and Viral Infections: A Double-Edged SwordT Cell Migration in Rheumatoid ArthritisCXCL12 chemokine and GABA neurotransmitter systems crosstalk and their putative rolesCXCL12 chemokine and its receptors as major players in the interactions between immune and nervous systemsMorphine increases brain levels of ferritin heavy chain leading to inhibition of CXCR4-mediated survival signaling in neuronsNeuronal ferritin heavy chain and drug abuse affect HIV-associated cognitive dysfunction.The triplet puzzle theory indicates extensive formation of heteromers between opioid and chemokine receptor subtypes.IL1R2, CCR2, and CXCR4 May Form Heteroreceptor Complexes with NMDAR and D2R: Relevance for Schizophrenia.Fluorescence resonance energy transfer imaging reveals that chemokine-binding modulates heterodimers of CXCR4 and CCR5 receptors.Further studies on lead compounds containing the opioid pharmacophore Dmt-Tic.Chemokine receptor oligomerization and allostery.Autoantibodies to the delta-opioid receptor function as opioid agonists and display immunomodulatory activityOpioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis.Alterations of CXCR4 function in μ-opioid receptor-deficient glia.β2-Adrenergic receptor signaling in the cardiac myocyte is modulated by interactions with CXCR4Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10.Stabilization of functional recombinant cannabinoid receptor CB(2) in detergent micelles and lipid bilayers.Recent advances on the δ opioid receptor: from trafficking to function.In vivo opioid receptor heteromerization: where do we stand?Activation of cannabinoid type 2 receptors inhibits HIV-1 envelope glycoprotein gp120-induced synapse loss.Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and deathBiological Significance of GPCR Heteromerization in the Neuro-Endocrine SystemDelta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches.Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor ProgressionMolecular Pharmacology of δ-Opioid Receptors.Regulation of neuronal ferritin heavy chain, a new player in opiate-induced chemokine dysfunctionResistance to human immunodeficiency virus type 1 (HIV-1) generated by lentivirus vector-mediated delivery of the CCR5{Delta}32 gene despite detectable expression of the HIV-1 co-receptors.Chemokine signaling in cancer: one hump or two?Modulation of chemokine receptor activity through dimerization and crosstalkG Protein-Coupled Receptor Heteromers.Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer.Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuseG-protein-coupled heteromers: regulation in diseasePharmacological modulation of chemokine receptor function.Mechanisms regulating chemokine receptor activity.CXCL12 signaling in the development of the nervous system.Octreotide long-acting repeatable for acromegaly.Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin ReceptorsFunctions of the chemokine receptor CXCR4 in the central nervous system and its regulation by μ-opioid receptors.
P2860
Q24619974-7310EFC9-5971-41EA-A594-5F420C995ABAQ26742182-58912956-AF0F-47BA-9AD0-64AAE591E1CAQ26797338-C82FFB92-B1B2-482C-A6C7-B4978A39E5ABQ26859215-9537940C-2DE3-4B18-A997-33530C5B2768Q26992010-2DFDD471-6C14-40EE-B9A1-1432F90338F1Q28566402-E81B5755-8F1B-463F-83D5-921DED33EE27Q30569766-E519C23E-874E-4256-977C-44CFA388400CQ33361044-5F530797-3D0B-4F3D-9CC8-039C42B2889BQ33364911-E98F8ECD-D3ED-4A3D-9612-7AC736F2D6D6Q33377026-6863A10D-E37C-4DEB-A6E1-E25961A14F10Q33613159-1C67C343-3673-46A3-AF5A-EE0FCE60448CQ33810517-A2DFEC71-8F3A-428E-A0F2-1A1B9140A4B4Q33817905-1C48065E-A10A-474D-81C7-881DED556100Q33842214-9C0FD686-FFEC-4CE7-AE38-02C5B6354596Q34209473-5F68A410-0660-4C3E-AAF6-39A2E8F0AED6Q34297873-EC2C7501-BE04-4205-BFB3-A04C1BAF5D27Q34424009-020462B1-4D09-4E15-9CFC-428E4FE473C5Q34441289-427BC4BC-FF52-4C4F-B762-BA075D2101BBQ34939664-3164B7DC-F1DA-4C26-94CA-C52AF54BCAB5Q34939677-80FA4C88-B4A2-41BD-8BAC-C790F02C36C4Q35188105-34BC3B0C-488E-45AF-B72F-B0F1AFF87D47Q35779848-EA6FAA2F-D082-429E-8CF3-99F7DE1E7670Q35971498-4AAAB2C3-3C8F-433E-B54C-80D0D5B0D32CQ36438816-C2216189-9E0B-447E-B3F6-267438683BCCQ36876322-70AD6D0D-3FCF-4A35-BEAB-2FD0F858A577Q37062556-F1E636AA-5FAF-441B-B575-E3BC572FD4CDQ37149240-FBABBC15-01C2-4755-9782-606FBB158A32Q37185404-9EFD75ED-9890-4117-8A09-FE917B79FB26Q37222198-AA415497-91F4-48FE-882D-41C83D96F353Q37355817-C23A16C3-7CF4-402D-A3D5-353C7805658EQ37489251-5FAA9672-B137-4426-8F88-1C1AB7F8F9A7Q37573308-8247D1A0-ECD3-4535-BE77-63D10AD9A837Q37680038-3DA1B775-74EF-4F01-BF5B-C451F0E300BAQ37686142-BF802B26-0FFF-4FC6-9608-1252BA19D29EQ37893687-8AD3BEF0-5FD5-41DC-8BF3-297285AB44A9Q37942973-102189C5-F1CC-4D80-A84D-6D4DE542FD9AQ37978185-C25130BF-0071-4FB2-A6FF-2FBF663F92F2Q37990556-0E4FA698-5F8E-4069-9D79-7FD82B6AF924Q38166623-E53A5CE4-14CD-4491-B4E9-6E87D377F8EEQ38245110-68517E4A-EDBC-4127-A2D4-9833749E45AE
P2860
Ligand stabilization of CXCR4/delta-opioid receptor heterodimers reveals a mechanism for immune response regulation.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Ligand stabilization of CXCR4/ ...... or immune response regulation.
@en
type
label
Ligand stabilization of CXCR4/ ...... or immune response regulation.
@en
prefLabel
Ligand stabilization of CXCR4/ ...... or immune response regulation.
@en
P2093
P50
P356
P1476
Ligand stabilization of CXCR4/ ...... for immune response regulation
@en
P2093
Carlos Martínez-A
Laura Martínez-Muñoz
María José Toro
María Monterrubio
Oscar M Pello
Pilar Lucas
Verónica Parrillas
P304
P356
10.1002/EJI.200737630
P407
P577
2008-02-01T00:00:00Z